Gauss Partners with Evive to Launch Mobile App for COVID-19 Testing and Research
Gauss, a leading developer of digital decision-support tools for the medical frontlines, in partnership with Evive, the leader in enterprise communications and benefits engagement, has today announced the nationwide release of Apollo, a free Apple iOS app and WebApp, to help increase safety and efficiency of drive-through COVID-19 screening and testing for patients and health workers. The app will also facilitate Stanford Medicine’s Apollo COVID-19 Screening Survey (Apollo Study). Apollo helps people determine if they are likely to qualify for COVID-19 testing based on CDC guidelines and helps them find a nearby testing facility from a nationwide directory.
Read More →
Hillel’s Tech Corner: Clues to the COVID-19 crisis
CLEW Medical are literally navigating the maze of patient data providing clues where they are most needed and where there would otherwise be none.
Read More →
Carnation Ambulatory Monitor patch used to detect arrhythmias in COVID-19 patients
Bardy Diagnostics has announced that its Carnation Ambulatory Monitor (CAM) Patch has been chosen for use in protocols to measure QT Segments in COVID-19 patients who have been prescribed hydroxychloroquine (HCQ). BardyDx’s CAM Patch will be utilised in newly established protocols at hospitals across the Seattle area to monitor cardiac rhythms for COVID-19 patients on HCQ after hospital discharge, as well as for outpatients.
Read More →
SilverCloud Health Raises $16M in Series B Funding
The company intends to use the funds to further expand program offerings in North America, enhance the current global portfolio, and conduct additional research and clinical trials. The company’s mental health programs are currently used globally by more than 300 organizations and by more than 350,000 users.
Read More →
Nanomix Awarded BARDA Contract for Development of Rapid, Mobile, Point-of-Care Assays to Detect COVID-19 Infection
Nanomix, a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that the company has been awarded up to approximately $570,000 in funding from Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. These funds support development and testing of COVID-19 point-of-care tests that will run on the Nanomix eLab analyzer, which provides results in less than 15 minutes.
Read More →
Spire Health Helps Pulmonary, Critical Care & Sleep Disorders Institute of South Florida Remotely Monitor High Risk Patients in Fight Against Coronavirus
Spire Health, the leading digital healthcare company for continuous respiratory remote patient monitoring, and PCSI, a large outpatient pulmonary group in the Palm Beach area of Florida, announced today a collaborative partnership to remotely monitor chronic respiratory disease patients from home in an effort to help PCSI healthcare providers detect early signs of COVID-19 and limit exposure for healthy patients.
Read More →
OrthoPediatrics Corp. Announces Acquisition of ApiFix Ltd. with FDA-Approved Non-Fusion Scoliosis Technology
Mark Throdahl, President and Chief Executive Officer of OrthoPediatrics, commented, “We believe that ApiFix fills a major treatment gap that could potentially allow patients to avoid fusion surgery. We estimate that non-fusion procedures will grow significantly as patients, their families, and surgeons recognize non-fusion’s benefits."
Read More →
Selective endovascular cooling with TwinFlo catheter shows promise for neuroprotection in stroke patients
Ron Solar and colleagues report in EuroIntervention that the TwinFlo catheter (ThermopeutiX), in pigs, was associated with rapid, selective, deep cerebral hypothermia. They add that the catheter may “offer an improved method for neuroprotection during neurosurgery, cardiac arrest, acute stroke, and other ischaemic insult”. Solar talks to BIBA Briefings about the role of hypothermia in neuroprotection.
Read More →
Bardy Diagnostics™ Announces Use of The Carnation Ambulatory Monitor Patch to Measure QT Segments in COVID-19 Patients Using Hydroxychloroquine
SEATTLE, March 25, 2020 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today that its Carnation Ambulatory Monitor (“CAM™”) Patch has been chosen for use in protocols to measure QT Segments in... Read More →
Duo device for tricuspid repair records first successful use in humans
CroíValve has announced the successful first human use of its Duo Tricuspid Coaptation Valve technology for tricuspid repair. The company says the procedure was performed by an experienced heart team in St James’ University Hospital (Dublin, Ireland).
Read More →